UNCY
Unicycive Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.80
+0.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 2.66x
- P/E 2028E
- 0.58x
- P/S forward
- 2.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.51x
- Price / sales
- —
- Price / cash flow
- -4.80x
Enterprise value
- Enterprise value
- $73.0M
- EV / sales
- —
- EV / EBITDA
- -2.11x
- EV / EBIT
- -2.20x
- Market cap
- $133.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026